BirthGlide

🤰 A study led by Arri Coomarasamy has been named one of 2023’s most notable and impactful in clinical medicine by the renowned NEJM Group (New England Journal of Medicine). Post-partum bleeding accounts for 27% of all maternal deaths worldwide – disproportionately affecting mothers in low- and middle-income countries which account for 86% of all maternal deaths. The E-MOTIVE trial found that a new care bundle reduced severe post-partum haemorrhage, postpartum laparotomy or maternal death by 60%, and has also been selected by the Bill & Melinda Gates Foundation as one of just seven interventions that can save the lives of 2 million mothers and babies by 2030. Read about the E-MOTIVE trial - and NEJM's full list of impactful studies - here: https://lnkd.in/dsB_N44h University of Birmingham Birmingham Women's and Children's NHS Foundation Trust Ammalife

Yesterday marked a milestone as we celebrated the culmination of our inaugural #AcceleratingFemTech programme! The day featured a packed agenda with insights and reflections from key opinion leaders in #WomensHealth, as well as valuable networking opportunities. Kicking off with a warm welcome from our Commercial Director, Anna King, attendees also heard a special speech from Viscount Camrose Jonathan Berry, the Minister for Artificial Intelligence and Intellectual Property, Parliamentary Under Secretary of State for the Department for Science, Innovation and Technology. Our 12 #FemTech innovators then took on a competitive pitching session, evaluated by our esteemed panel of judges: DigitalHealth.London's Programme Director Sara Nelson, Candesic's FemTech Expert Suzanne Coles, Royal College of Obstetricians and Gynaecologists | RCOG's CEO Kate Lancaster, and NHS England's National #Digital Midwife Lead for Maternity Jules Gudgeon. A massive congratulations to Bloomful, Plexāā, and IBEX Innovations for winning 'Most Engaging Pitch,' 'Biggest Potential to be the Most Revolutionary for Women's Health in the UK,' and 'Greatest Potential Benefit to the #NHS/Industry' respectively! The second panel of the day featured Innovate UK's Head of Health Technologies Samana Brannigan, SmartCo Consulting's Women's Health Lead Katherine Church, Mills & Reeve's Principal Associate Commercial Health Charlotte Lewis, and London & Partners' Board Member Jo Pisani, who shared their insights in the exciting developments within the FemTech space. The session was skillfully chaired by our Operations Director, Mark Edginton. The last panel delved into bringing women's #health #innovation to life. Chaired by our Medical Director Natasha Curran, the session featured valuable sharing from South West London Integrated Care System's Chair Michael Bell and Deputy Director of Innovation and Transformation Jayne Thorpe, University College London Hospitals NHS Foundation Trust's Consultant Urogynaecologist and Uro-neurologist Sohier Elneil, and #DHLAccelerator alumnus getUBetter's Founder and CEO Carey McClellan. The event concluded with a closing keynote from Royal College of Obstetricians and Gynaecologists | RCOG's Vice President for Academia and Strategy Asma Khalil, who shared her work on HaMPton, an app enabling pregnant women to monitor blood pressure at home. A big shoutout to all 12 of our Accelerating FemTech companies for completing this ten-week journey of innovation, learning, and growth. Adora Digital Health, BirthGlide, Bloomful, Bloume Health, Ellescope, IBEX Innovations, Joii, LBN Innovations, P.Happi, Platinum Medica ltd, Plexāā, Ru Medical - we are incredibly proud of your achievements! 🎉